Document is current
Any future updates will be listed below
-
Authors
Zhou, Yitian
Lauschke, Lukas M.
Lauschke, Volker M.
-
Funding
Funding for this research was provided by:
Karolinska Institute
- License Information
-
More Information
Article History
Received: 19 December 2025
Accepted: 25 March 2026
First Online: 4 April 2026
Declarations
:
: VML is co-founder, CEO and shareholder of HepaPredict AB, as well as co-founder and shareholder of Shanghai Hepo Biotechnology Ltd. All other authors declare that they have no competing interests.
